Continuing Education Information
CME, CCP, P.A.C.E®., NSGC Educational Credits
Continuing Medical Education (CME)
The American College of Medical Genetics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Medical Genetics and Genomics designates this other activity for a maximum of 71.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
(total includes Short Courses)
The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country.
Non-physicians may request a certificate of attendance for their participation.
ABMGG Lifelong Learning and Self-Assessment(CCP Part II)
ABMGG diplomates must demonstrate involvement in continuing education as part of the Lifelong Learning and Self-Assessment (Part II) requirement of the ABMGG Continuing Certification Program (CCP). The ABMGG has approved participation in the short courses offered at the 2020 ACMG Annual Clinical Genetics Meeting as alternative activities for the ABMGG literature review modules. Successful completion of a short course, including participation in the evaluation component, enables the participant to earn a certificate of completion for submission via the ABMGG Portal to fulfill this requirement.
ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program.
ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). This course is registered with CEBroker. ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.®. This activity has been approved for 71.5 P.A.C.E.® CEU's. (inclusive of Short Courses)
National Society of Genetic Counselors (NSGC)
This event has been submitted to the National Society of Genetic Counselors (NSGC) for approval of Category 1 CEUs. The American Board of Genetic Counseling (ABGC) accepts CEUs approved by NSGC for purposes of recertification. Approval for the requested CEUs and Contact Hours is currently pending.
The 2021 ACMG Annual Clinical Genetics Meeting – a virtual experience begins with a two-hour interactive session on Thursday, April 8th entitled “Laboratory Diagnostic Challenges”, a session favorite of real cases that are solved or unsolved. Then on Tuesday, April 13th we offer two short courses, student and trainee sessions and an informatics workshop. Wednesday through Friday April 14 – 16 we have more than 40 additional sessions including live panel discussions and live TED-Style presentations. Additionally, we have extra programming with Online Exclusive sessions that you can watch 24/7 in the virtual platform. The virtual platform will remain open until Friday, July 16, 2021 at 11:59 pm ET. After you view any session you will be able to claim educational credits by completing a session evaluation (no test). The 2021 Digital Edition will be achieved in the ACMG Genetics Academy and will be available July 19, 2021.
Session listing with available credits
ACMG Conflict of Interest Policy
The American College of Medical Genetics and Genomics has implemented a process where everyone who is in a position to influence and/or control the content of a continuing education activity must disclose all relevant financial relationships with any commercial interest within the past 12 months and any conflicts must be resolved prior to the activity. Participants of educational programs must be informed of an organizer’s and/or a presenter’s academic and professional affiliations and existence of any relevant financial relationship a presenter has with any proprietary entity producing heath care goods or services consumed by, or used on patients, with the exemption of non-profit or government organization and non-health care related companies. The intent of this disclosure is not to prevent a speaker from making a presentation. This policy allows the participant to be fully knowledgeable in evaluating the information being presented. All disclosures have been reviewed by the COI sub-committee conflicts of interest are resolved. Disclosure includes any relevant relationship that may potentially bias the planning of the continuing education activity or may potentially bias one’s presentation or which, if known, could give the perception of bias.
The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. All educational programming is developed and must be presented in compliance with all ACCME accreditation requirements.
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the American College of Medical Genetics and Genomics must insure balance, independence, objectivity, and scientific rigor in all educational activities. Planning must be free of the influence or control of a commercial entity, and promote improvements or quality in healthcare. All scientific research used to support patient care recommendations must conform to generally accepted standards of experimental design, data collection, and analysis. In accordance with the ACCME Standards for Commercial Support, everyone (speakers, moderators, oral abstract presenters, all authors, committee members, and staff) who are in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit™
must disclose all relevant financial relationships with any commercial interests within the past 12 months. Individuals who do not disclose are disqualified from participating in a CME activity. Should the speaker’s presentation include discussion of any off-labeled/investigational use of a commercial product, he/she is also required to disclose this to the activity participants.
Conflict of interest is created when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest. The potential for maintaining or increasing the value of the financial relationship with the commercial interest creates an incentive to influence the content of the CME—an incentive to insert commercial bias. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research and clinical trials), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected.
A Commercial interest
is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
A diagnostic laboratory is not considered an ACCME-defined commercial interest if its business is limited to the provision of diagnostic services that provide clinical results or information to healthcare professionals for their treatment of patients.
A diagnostic laboratory is considered an ACCME-defined commercial interest if it produces, markets, distributes, or re-sells proprietary diagnostic products or devices to other entities o individuals, such as other laboratories, clinics, clinicians, or patients for the provision of clinical service—for example, providing on-site or in-home clinical results.
A diagnostic laboratory that is owned or controlled by an ACCME-defined commercial interest is considered an ACCME-defined commercial interest.
Relevant financial relationships as defined by the ACCME requires anyone in control of CME content to disclose relevant financial relationships to the accredited provider. Individuals must also include in their disclosure the relevant financial relationships of a spouse or partner.
Content Validation and Fair Balance
1. ACMG follows the ACCME policy on Content Validation for CME activities, which requires:
a) All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for thei indications and contraindications in the care of patients.
b) All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis.
2. Activities that fall outside the definition of CME/CE; “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients.
3. Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality. If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.
Off-label Uses of Products
When an off-label use of a product, or an investigational use not yet approved for any purpose, is discussed during an educational activity, the accredited sponsor shall require the speaker to disclose that the product is not labeled for the use under discussion, or that the product is still investigational. Discussions of such uses shall focus on those uses that have been subject of objective investigation.
HIPAA Compliance by Faculty
The ACMG supports medical information privacy. While the ACMG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ACMG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ACMG-sponsored events has been properly authorized. All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information. If so, they were asked either to at that a HIPAA-compliant consent form is on file at their institution, or to send ACMG a copy of the HIPAA compliance form. This information is on record at the ACMG Administrative Office and will be made available upon request.
ACMG educational programs are designed primarily as an educational tool for health care providers who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse, or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and s or exclusive of other procedures and s that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or , a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.
Questions regarding CE credit should be directed to firstname.lastname@example.org